Univariate log-rank test analysis of factors associated with survival in 19 patients with PEL treated with modified EPOCH
Variable . | P . |
---|---|
Platelets (above vs below median) | .10 |
Hemoglobin (above vs below median) | .24 |
Albumin (above vs below median) | .64 |
CRP (above vs below median) | .99 |
Ferritin (above vs below median) | .054 |
Lactate dehydrogenase (above vs below median) | .15 |
IgG (above vs below median) | .21 |
IgE (above vs below median) | .019 |
κ FLC (above vs below median) | .87 |
Λ FLC (above vs below median) | .87 |
CD4+ (above vs below median) | .82 |
HIV <100 copies/mL | .71 |
KSHV viral load (above vs below median) | .51 |
Tumor EBV status | .029 |
Clinical Kaposi sarcoma | .61 |
KSHV-MCD | .39 |
Previous doxorubicin/liposomal doxorubicin | .63 |
Rituximab with therapy | .21 |
Bevacizumab | .84 |
High-dose methotrexate | .54 |
Protease inhibitor–based antiretroviral regimen | .30 |
IL-6 (above vs below median) | .013 |
IL-8 (above vs below median) | .60 |
IL-10 (above vs below median) | .041 |
INF-γ (above vs below median) | .37 |
TNF-α (above vs below median) | .26 |
Variable . | P . |
---|---|
Platelets (above vs below median) | .10 |
Hemoglobin (above vs below median) | .24 |
Albumin (above vs below median) | .64 |
CRP (above vs below median) | .99 |
Ferritin (above vs below median) | .054 |
Lactate dehydrogenase (above vs below median) | .15 |
IgG (above vs below median) | .21 |
IgE (above vs below median) | .019 |
κ FLC (above vs below median) | .87 |
Λ FLC (above vs below median) | .87 |
CD4+ (above vs below median) | .82 |
HIV <100 copies/mL | .71 |
KSHV viral load (above vs below median) | .51 |
Tumor EBV status | .029 |
Clinical Kaposi sarcoma | .61 |
KSHV-MCD | .39 |
Previous doxorubicin/liposomal doxorubicin | .63 |
Rituximab with therapy | .21 |
Bevacizumab | .84 |
High-dose methotrexate | .54 |
Protease inhibitor–based antiretroviral regimen | .30 |
IL-6 (above vs below median) | .013 |
IL-8 (above vs below median) | .60 |
IL-10 (above vs below median) | .041 |
INF-γ (above vs below median) | .37 |
TNF-α (above vs below median) | .26 |